Showing results (11-20 of 299) with videos related to
Sort By:
Pageof 30
Biochemical Pharmacology|March 21, 1997
Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) functionU Vanhoefer, M B Yin, A Harstrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Irinotecan in the treatment of colorectal cancer: clinical overviewU Vanhoefer, A Harstrick, W Achterrath, et al.British Journal of Cancer|July 1, 1996
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell linesU Klaassen, A Harstrick, N Schleucher, et al.Oncology (Williston Park, N.Y.)|August 12, 1999
Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancerU Klaassen, D Borquez, S Lang, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitroU Vanhoefer, A Harstrick, H Wilke, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinomaD Strumberg, J Erhard, A Harstrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancerU Vanhoefer, A Harstrick, C H Köhne, et al.Journal of Clinical Apheresis|June 4, 1999
Kinetic study of CD34+ cells during peripheral blood stem cell collectionsP Bojko, W Stellberg, C Küdde, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitorsY M Rustum, A Harstrick, S Cao, et al.Anti-Cancer Drugs|October 1, 1995
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell linesA Harstrick, U Vanhoefer, N Schleucher, et al.Pageof 30